Manufactures and supplies high-quality products for MRI, with a special focus on the fast growing field of functional imaging
With over a decade of experience, NordicNeuroLab (NNL) provides products and solutions that define the field of functional MR imaging. We understand the growing need for reliable and innovative tools in this growing field. As a result, we closely collaborate with research and clinical teams from both academic and medical centers, MR system manufacturers, and third party vendors to develop and manufacture hardware and software solutions that meet the needs of very experienced centers while developing training programs to make fMRI easy to adopt for more novice users.
The Association of the Pharmaceutical Industry in Norway - LMI Norwegian and foreign pharmaceutical companies selling medicinal products in Norway have their own trade organisation, Legemiddelindustriforeningen (LMI) – The Association of the Pharmaceutical Industry in Norway. LMI is working opposite the authorities, with the image and reputation of the industry, providing services towards the member companies, as well as making case assessments and supplying statistical reports. The association organises courses and training activities, e.g. conducting training courses for medical sales representatives and clinical trial monitors. LMI actively participates in international industry associations for manufacturers of pharmaceutical products.
Merck & Co., Inc. is a global research-driven pharmaceutical company established in 1891.
Merck discovers, develops, manufactures and markets vaccines, consumer health products, animal health products and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. MSD Norway was established in 1970 and holds 160 employees in its branch in Drammen. MSD Norway is very active with clinical trials in Norway in addition to marketing and sales of innovative medicines.
Pfizer is the world's largest pharmaceutical company
We have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer's disease and cancer.
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company
We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.
How do we know where we are, where we have been and where we are going? Such are the questions that the Kavli Institute for Systems Neuroscience at the Norwegian University of Science and Technology (NTNU) in Trondheim aims to answer. The Institute seeks to unlock the secrets of memory by studying the neural microcircuits and networks in the hippocampus and associated areas of the brain, where memory is encoded, stored and retrieved. It focuses in particular on the memory of place and direction that underlies our spatial navigation skills.
Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value from krill harvesting and processing.
Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value krill derived biotech products. The company is supplying biomarine ingredients through an optimized value chain from raw materials to customer.
BioChromix AB is a Swedish in vitro diagnostic company founded in 2004.
BioChromix is an innovative company active on the life science arena that develops and commercializes unique products for early stage diagnostics of Alzheimer’s disease (AD).
Boehringer Ingelheim belongs to the group of the 20 most leading pharmaceutical companies in the world.
The headquarter is situated in Ingelheim in Germany. The company operates globaly with more than 142 companies in 50 counties and employs more than 41 500 poeple. The company was established in 1885 and is a family owned pharmaceutical company which emphesize the importance of research and development , productiom and marketing of innovative products of high therapeutic value for animals and humans.
BTO commercialise research results and handle all intellectual property (IP) aspects on behalf of 8 research institutions in Bergen
Bergen Teknologioverføring AS (BTO) is located in Bergen at the west coast of Norway. BTO was founded December 2004 by the University of Bergen, Haukeland University Hospital and the Institute of Marine Research. BTO and other technology transfer offices in Norway was established following a law change granting universities and colleges in Norway the right to commercially exploit patentable inventions by employees.
Commercialization unit of NTNU, the Norwegian University of Science and Technology
Our mission: We create value by matching science and industry – by harnessing new knowledge as it emerges from the university and transforming inventions into new business opportunities in the marketplace.
Commercializing innovations from University of Oslo, Oslo University Hospital and the southern health region of Norway
Inven2 is the next-generation innovation company, established to maintain and develop Norwegian innovations. We build bridges between excellent research and the next generation technology based industry.
Inven2 is the largest contributor in Norway within the field of commercialization of research, owned by the University of Oslo and Oslo University Hospital, Norway's largest and leading university and hospital representing pioneering research.
Conducting basic and translational research within the areas of synaptic transmission and plasticity in the neurosystem
The Neuroscience Research Group consists of six principle investigators conducting basic and translational research within the areas of synaptic transmission and plasticity in the hippocampus, memory mechanisms and hippocampal function, neural mechanisms related to regulation and transmission of pain, synaptic and cellular mechanisms of visual processing, sleep mechanisms, cognitive function and depression, and applied image analysis and neuroinformatics.
Department of Neuroscience conducts studies and research in a variety of disciplines, including basic and clinical neurosciences, geriatrics, psychiatry, sense organs, neuro- and oral surgery, orthopaedics, rheumatology, and health informatics. The department also comprises several national centres of competence in addition to the Centre for the Biology of Memory, which is a Centre of Excellence. Our research groups are located at St. Olavs University Hospital and its surroundings.
Creating a link between clinical practice, applied-, and basic research in the fields pertaining to minimally invasive and image guided therapy
The Interventional Centre is a research and development centre for medcial imaging, image guided and minimally invasive therapy at Oslo University Hospital in Oslo, Norway and Faculty of Medicine at University of Oslo. The centre was established in 1996.
Developing patient-friendly diagnostic tests for the early detection of devastating diseases where early intervention is crucial for successful treatment.
DiaGenic ASA is an innovative Norwegian in vitro diagnostic company founded in 1998 and listed on the Oslo Stock Exchange. DiaGenic's patented method is based on identifying disease-specific gene expression signatures from easily available sample material such as blood.
develops technology to carry out analysis of huge sets of data
Pattern Solutions develops technology to carry out analysis of huge sets of data. Such a field is denoting datamining or pattern recognition. In addition the company carries out consutative services on the technology that is developed. By use of technology from Pattern Solutions one can carry out analyis of many different sets of data to identify for instance deseases in an early phase such as cancer, autism, ADHD, Epilepsy, etc.
Discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders
Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. We are the world's oldest independent biotechnology company and a Fortune 500 company with more than $4 billion in revenues. Patients worldwide benefit from our products.
dPCom A/S is a Norwegian Med-Tech company, which allows healthcare professionals to safely and accurately monitor pressures in patients
dPCom A/S is a Norwegian medical technology company, which allows healthcare professionals to safely and accurately monitor pressures in patients. The company has developed a new innovative technology that significantly improves the diagnostic information from invasive and non-invasive pressure measurements, focusing on intracranial pressure (ICP) and blood pressure (ABP). The new method is suitable for use in intensive care units (ICU) for the monitoring of brain disease/injury, and for diagnostic pressure monitoring in general.
Drugs delivery solutions to targeted, hard to reach areas of the body
OptiNose’s innovative breath-powered nasal delivery technology is designed to efficiently and reliably deliver drugs to targeted, hard-to-reach areas to treat a variety of medical conditions. In the case of OptiNose, our “way in” is through the nose and the area of targeted drug delivery is the nasal cavity. We have created an elegant, simple-to-use device based on our breakthrough technology which uses the natural function of a patient’s breath to propel medications into the nasal cavity more consistently and efficiently than current treatment approaches.
Hermo Pharma is engaging in developing novel disease-modifying treatments for amblyopia, Parkinson’s disease and Alzheimer’s disease.
Hermo Pharma Ltd. is a biopharmaceutical company which aims to discover and develop cutting-edge therapeutic approaches for currently unmet medical needs, particularly in the field of neurology. The company’s R&D programs are based on the following scientifically innovative concepts: neuroprotection, neuroregeneration and neurplasticity. These concepts are being developed through preclinical and early clinical development phases with the aim of gaining partners prior to late clinical development phases and finally marketing.
Holberg EGG has developed a standardized system for interpretation of EEG.
Holberg EEG is a company established in 2009, in Bergen, Norway, with main focus on taking clinical and research use of electroencephalography (EEG) to the next level. Our products are built by experienced clinical neurophysiologists and software developers that together are our most valuable resource. Holberg EEG products are unique software applications integrated with your EEG reader with a valuable fast and easy EEG reporting system based on the new standardized descriptions SCORE.
Lundbeck is a global pharmaceutical company working with Brain disorders
Lundbeck is a global pharmaceutical company conducting research into developing, manufacturing, marketing, selling and distributing pharmaceuticals for the treatment of disorders of the central nervous system (CNS), including depression, schizophrenia, Alzheimer’s disease, Parkinson’s disease, Huntington's disease, epilepsy and insomnia.
Manufactures intraoperative imaging system for neuronavigation
SONOWAND is a Norwegian owned company, established in Trondheim in 1998. The company was originally named MISON, but changed the name to SONOWAND in 2007.. Since the very beginning our company has been known for SonoWand® - a high quality 3D ultrasound based intraoperative imaging system. The system provides high accuracy and ensures optimal image quality throughout the entire surgical procedure.
Network of Norwegian research groups and clinicians studying brain development
The Norwegian Consortium on Brain Development assembles a uniquely interdisciplinary network of Norwegian research groups and clinicians studying brain development, from its earliest stages in the womb to formative events during childhood and early adulthood. The Norwegian Consortium on Brain Development currently includes researchers from basic research and clinical departments at the University of Oslo, Oslo University Hospital, the University of Bergen, Haukeland Hospital, the Norwegian University of Science and Technology, and St Olavs Hospital. It also maintains a far-reaching network of collaborations with research and clinical institutions around the world.
Norwegian Centre of Excellence at the University of Oslo and Rikshospitalet, Oslo University Hospital.
The Centre for Molecular Biology and Neuroscience (CMBN) (Senter for molekylærbiologi og nevrovitenskap) is a CMBN shall take on a leading role in elucidating the role of DNA repair and genome maintenance mechanisms in preventing neurological disease and brain ageing.
Novartis has a diverse healthcare portfolio, including innovative pharmaceuticals, eye care products, generics, consumer health products, and vaccines and diagnostic tools
Novartis was created in 1996 through the merger of Ciba-Geigy and Sandoz, two companies with a rich and diverse corporate history. Throughout the years, Novartis and its predecessor companies have discovered and developed many innovative products for patients and consumers worldwide.
Offers access to a fully established Norwegian population-based prospective biobank
HUNT Biosciences offers the life-science and biopharma industry unique access to the HUNT Bio- and Databank, a fully established Norwegian-population-based prospective health survey and biobank. The HUNT Databank comprises more than 5,500 data variables, medical records, clinical measurements, environmental exposures, and biological samples collected through 30 years in three phases from a regional cohort of 130,000 individuals.
Otivio has developed the Thermotube, which is a non-invasive patient temperature management system to be applied on arm or leg
Otivio AS was founded January 2010 based on technology developed by the medical doctors Erling Bekkestad Rein and Marius Filtvedt. Based on their advanced understanding of physiology and medicine, they developed an instrument that would maintain optimal body core temperature in patients, and thereby improve patient survival and recovery rates. The focus was on treating or preventing hypothermia.
Redcord is a unique and effective concept for functional training
Carefully designed training using body weight and slings is at the core of the concept. A unique blend of applied scientific knowledge, patented equipment and guided advice from a certified professional ensures the Redcord system gets results. Bridging the gap between performance oriented training and rehabilitation from injury is characteristic of Redcord’s total and holistic approach.
Smartfish is a Norwegian biotech company developing synergistic, omega 3 based emulsions of active nutrients for brain health, heart health, immune system and recovery
Smartfish emulsions have a potent content of fresh (low-oxidised) marine omega 3. Specific applications have been developed for clinical nutrition, nutraceuticals/nutritional drinks, nutritional supplements and sports performance nutrition. The main purpose and emphasis of Smartfish is to develop nutritional solutions which modulate underlying mechanisms involved in specific diseases – Pharmaconutrition This approach -and products – contribute to prevention, early treatment, and support during medical treatment of chronic diseases.
The Bergen fMRI Group is an interdisciplinary research group at the University of Bergen (UiB) and Haukeland University Hospital with interests in functional Magnetic Resonance Imaging (fMRI).
The Bergen fMRI Group is an interdisciplinary research group at the University of Bergen (UiB) and Haukeland University Hospital with interests in functional Magnetic Resonance Imaging (fMRI). The research is focused on brain activation studies related to a broad spectre of cognitive functions, including laterality, speech and language, working memory, attention, cognitive control and emotions. The group is also involved in research related to voxel-based morphometry, perfusion/diffusion imaging, diffusion tensor imaging, spectroscopy, EEG and neuroinformatics, using a range of statistical tools and software.
Supported by Innovation Norway. Copyright © 2012 NansenNeuroScience. All Rights Reserved. Web support: Sustainovate